摘要
目的 :观察怡开 (胰激肽原酶肠溶片 )对 2型糖尿病 (T2DM)早期肾病的疗效。方法 :5 8例T2DM早期肾病患者 ,随机分成对照组和治疗组 ,在常规降糖药物治疗同时 ,治疗组口服怡开 ,3个月后比较治疗前后尿微量白蛋白 (UAER)的变化。结果 :怡开组治疗后可显著减少尿微量白蛋白的排出量 (P <0 .0 1 ) ,对照组治疗前后UAER无明显差异 (P >0 .0 5 )。结论 :怡开可降低糖尿病尿微量白蛋白的排泄 。
Objective: To study the curative effect of YiKai(pancreatic kininogenase tablets) in the treatment of early diabetic nephropathy of type 2 diabetes. Method:50 patients with early diabetic nephropathy of type 2 diabetes were divided randomly into two groups: control group and treatment group.While treated with general hypoglycemic agent,the treatment group took Yikai orally for 3 months.After 3 months, compare the uninary albumin excretory rate(UAER)before and after therapy. Result: There was significant decrease of UAER in treatment group after therapy(P<0.01) and no significant difference in control group(P>0.05). Conclusion: Yikai can decrease UAER in patients and has a favorable curative effect on early diabetic nephropathy of type 2 diabetes.
出处
《河北医学》
CAS
2003年第10期911-913,共3页
Hebei Medicine